Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
1,642
Views
2
CrossRef citations to date
0
Altmetric
Research Article

IL-6, IL-1β and TNF-α regulation of the chondrocyte phenotype: a possible mechanism of haemophilic cartilage destruction

Liujie Zhenga Department of Orthopaedic Surgery, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
,
Zhiwei Hanb Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
,
Dasheng Luob Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
,
Jiale Lic Department of Orthopaedic Surgery, Fuyang Hospital of Anhui Medical University, Fuyang, People’s Republic of China
,
Nanyu Pangb Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
,
Mingyang Dingb Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
,
Houlong Yeb Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
,
Keyan Zhub Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of China
&
Yunfeng Yaob Department of Orthopaedic Surgery, The Second Hospital of Anhui Medical University, Hefei, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7118-2524
ORCID Icon show all
Article: 2179867 | Received 11 Oct 2022, Accepted 01 Feb 2023, Published online: 17 Feb 2023

References

  • Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801–1809.
  • Zhu H, Meng Y, Tong P, et al. Pathological mechanism of joint destruction in haemophilic arthropathy. Mol Biol Rep. 2021;48(1):969–974.
  • Srivastava A. Inflammation is key to hemophilic arthropathy. Blood. 2015;126(19):2175–2176.
  • Razzaque MS. Interactions between FGF23 and vitamin D. Endocr Connect. 2022;11(10):e220239.
  • Hasan M, Oster M, Reyer H, et al. Tissue-wide expression of genes related to vitamin D metabolism and FGF23 signaling following variable phosphorus intake in pigs. Metabolites. 2022;12(8):729.
  • Roumpou A, Yavropoulou MP, Chronopoulos E, et al. Novel therapeutic agents for rare diseases of calcium and phosphate metabolism. Horm Metab Res. 2022;54(10):645–657.
  • Bianchi A, Guibert M, Cailotto F, et al. Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner. Osteoarthritis Cartilage. 2016;24(11):1961–1969.
  • Kamachi Y, Kondoh H. Sox proteins: regulators of cell fate specification and differentiation. Development. 2013;140(20):4129–4144.
  • Jouan Y, Bouchemla Z, Bardèche-Trystram B, et al. Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice. Sci Adv. 2022;8(34):eabn3106.
  • Nishimura R, Hata K, Takahata Y, et al. Regulation of cartilage development and diseases by transcription factors. J Bone Metab. 2017;24(3):147–153.
  • Green JD, Tollemar V, Dougherty M, et al. Multifaceted signaling regulators of chondrogenesis: implications in cartilage regeneration and tissue engineering. Genes Dis. 2015;2(4):307–327.
  • Zheng L, Han Z, Luo D, et al. FGF23 and SOX9 expression in haemophilic cartilage: In vitro studies of the effects of iron. Haemophilia. 2022;28(6):1062–1068.
  • Mammen J, Nair SC, Srivastava A. External quality assessment scheme for hemostasis in India. Semin Thromb Hemost. 2007;33:265–272.
  • Payal V, Sharma P, Goyal V, et al. Clinical profile of hemophilia patients in Jodhpur region. Asian J Transfus Sci. 2016;10:101–104.
  • Oldenburg J. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. Blood. 2015;125(13):2038–2044.
  • Abshire T. Unraveling hemophilic arthropathy. Blood. 2011;117(8):2302–2303.
  • Abu-Zaid A, Magzoub D, Aldehami MA, et al. The effect of iron supplementation on FGF23 in chronic kidney disease patients: a systematic review and time-response meta-analysis. Biol Trace Elem Res. 2021;199(12):4516–4524.
  • Sikura KÉ, Potor L, Szerafin T, et al. Potential role of H-Ferritin in mitigating valvular mineralization. Arterioscler Thromb Vasc Biol. 2019;39(3):413–431.
  • Wang T, He C. Pro-inflammatory cytokines: the link between obesity and osteoarthritis. Cytokine Growth Factor Rev. 2018;44:38–50.
  • Rigoglou S, Papavassiliou AG. The NF-kappaB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 2013;45(11):2580–2584.
  • Durlacher-Betzer K, Hassan A, Levi R, et al. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018;94(2):315–325.
  • Ito N, Wijenayaka AR, Prideaux M, et al. Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Mol Cell Endocrinol. 2015;399:208–218.
  • Han X, Li L, Yang J, et al. Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages. FEBS Lett. 2016;590(1):53–67.
  • Nishimura R, Hata K, Takahata Y, et al. Role of signal transduction pathways and transcription factors in cartilage and joint diseases. Int J Mol Sci. 2020;21(4):1340.
  • Rubbert-Roth A, Furst DE, Nebesky JM, et al. A review of recent advances using Tocilizumab in the treatment of rheumatic diseases. Rheum Ther. 2018;5(1):21–42.
  • Ma X, Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep. 2013;1(2):177–184.
  • Alten R, Gomez-Reino J, Durez P, et al. Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study. BMC Musculoskelet Disor. 2011;12:153.
  • LiverTox: Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
  • Radner H, Aletaha D. Anti-TNF in rheumatoid arthritis: an overview. Wien Med Wochenschr. 2015;165(1-2):3–9.
  • Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002;2(5):364–371.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.